Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 23, 2020

View Archived Issues

Cholera toxin can subvert inflammation

Chip predicts intestinal drug metabolism

Phase I study of HBV candidate ZM-H1505R now recruiting

Phase IIb trial approved to evaluate SUBA-Itraconazole in prostate cancer

China NMPA accepts IND filing for TST-001 for solid tumors

FAM222A raises the risk of Alzheimer's disease

Master clock gene keeps macrophages asleep

Efficacy of siderophore-antibiotic conjugates in new mouse models of iron overload and depletion

Biogen presents new MAP3K5 inhibitors

Kinnate Biopharma describes CDK inhibitors

PTC Therapeutics discloses heteroaryl compounds for Huntington's disease

Incyte identifies PI3Kgamma inhibitors

Leo Pharma discovers JAK1 inhibitors

AKCEA-APOCIII-LRx meets primary endpoint in phase II hypertriglyceridemia trial

FDA clears IND for CYNK-001 in GBM

FDA clears IND application for HEALEY ALS platform trial

DIRC3 acts as a tumor suppressor in melanoma

Nubeqa approved in Japan for nonmetastatic castration-resistant prostate cancer

China's NMPA clears ASC-22 to begin trials for HBV in China

Altimmune demonstrates systemic antitumor activity with ALT-702 in preclinical study

Japanese approval of Dinagest for dysmenorrhea

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...